Could cancer vaccine mark a turning point in preventing relapse?

Name: Could cancer vaccine mark a turning point in preventing relapse?
Uploaded: 2023-06-05T15:00:00-04:00
Description: A vaccine being developed by French company Transgene that is tailored to each individual patient using artificial intelligence could help prevent relapses, says the company. The 4050 vaccine has already been successfully tested on a sample of 16 patients with head and neck cancers and could theoretically be used to treat a variety of different cancers.

From the Vigilantes take on criminal gangs in Haiti, and more of today's top videos series

Jun 5, 2023
Jun 5, 2023 Updated Jun 6, 2023
0

Prefer us on Google

A vaccine being developed by French company Transgene that is tailored to each individual patient using artificial intelligence could help prevent relapses, says the company. The 4050 vaccine has already been successfully tested on a sample of 16 patients with head and neck cancers and could theoretically be used to treat a variety of different cancers.

More in Vigilantes take on criminal gangs in Haiti, and more of today's top videos (3 of 8)